跳至主要内容
临床试验/NCT00607074
NCT00607074已完成不适用

Effects of Anti-Giardia and Antihelmintic Treatment on Infant Nutritional and Biochemical Status and Intestinal Permeability in Rural Bangladesh

University of Cambridge1 个研究点 分布在 1 个国家目标入组 410 人开始时间: 2003年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
410
试验地点
1
主要终点
nutritional status

研究概览

简要总结

This longitudinal study aimed to assess whether regular anti-Giardia and antihelmintic treatment improved growth and small intestinal mucosal function of rural Bangladeshi infants.

详细描述

A randomised double-blind controlled intervention of 36 weeks duration was conducted in a rural community located 40kms north-west of Dhaka, the capital of Bangladesh. Infants aged between 3 and 11 months were randomly assigned to either receiving anti-Giardia and antihelmintic treatment, or anti-Giardia treatment only, or a control group receiving placebos. Weight and supine length were recorded every 4 weeks. Every 12 weeks intestinal permeability (L/M ratio), haemoglobin, plasma albumin, alpha-1-acid glycoprotein, immunoglobulin G and Giardia intestinalis specific IgM titre (GSIgM) and eggs of the three common geohelminths and Giardia intestinalis cysts were determined.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
3 Months 至 15 Months(Child)
性别
All
接受健康志愿者

入选标准

  • infants living in the study area

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

干预措施: Anti-Giardia and antihelmintic treatment (secnidazole or albendazole) (Drug)

1

Experimental

干预措施: Anti-Giardia treatment only (secnidazole or albendazole) (Drug)

1

Experimental

干预措施: Control group (placebo) (Drug)

结局指标

主要结局

nutritional status

时间窗: 9 months

次要结局

  • intestinal permeability(9 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Impact of Anti-Giardia and Antihelmintic Treatment... | 临床试验